Search Form
First, enter a politician or zip code
Now, choose a category
 

Michael Burgess' Public Statements

Office: U.S. House (TX) - District 26, Republican
On The Ballot: Won, Republican for U.S. House - District 26
Date Title
Oct. 24, 2018 Burgess Joins President Trump as He Signs Law to Combat the Opioid Crisis
Oct. 24, 2018 POTUS Signs Landmark Opioid Legislation Into Law
Oct. 17, 2018 Burgess Introduces Measure to Combat Drivers of Irregular Migration
Oct. 10, 2018 POTUS Signs Bills to Lower Prescription Drug Costs by Eliminating Gag Clauses
Oct. 6, 2018 Burgess Statement on Senate Confirmation of Judge Brett Kavanaugh to the U.S. Supreme Court
Oct. 3, 2018 Bipartisan Opioids Package Headed to POTUS' Desk
Oct. 1, 2018 Letter to The Honorable Alexander Acosta, Secretary of Labor - Byrne Leads Bipartisan Letter Asking Acosta to Act on Joint Employer
Sept. 28, 2018 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Burgess, Hearing on Reducing Maternal Mortality in the U.S.
Sept. 28, 2018 Bipartisan Opioids Legislation Nearly to POTUS' Desk
Sept. 28, 2018 Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act
Sept. 28, 2018 Burgess Statement on House Passage of Sweeping Bill to Combat Opioid Abuse
Sept. 27, 2018 #SubHealth Examines Using Data To Reduce Maternal Mortality
Sept. 27, 2018 Letter to the Hon. Scott Gottlieb, Department of Health and Human Services Commissioner of Food and Drugs - Concerns Regarding the Office of Laboratory Science and Safety
Sept. 27, 2018 Letter to Uttam Dhillon, Acting Director of the Drug Enforcement Administration - Efforts to Halt Trafficking of Deadly Fentanyl
Sept. 27, 2018 Letter to the Hon. Kirstjen Nielsen, Secretary of Homeland Security - Efforts to Halt Trafficking of Deadly Fentanyl
Sept. 27, 2018 Letter to the Hon. Mike Pompeo, Secretary of State - Efforts to Halt Trafficking of Deadly Fentanyl
Sept. 26, 2018 Burgess Provision to Outlaw Armed Drones Passes House
Sept. 25, 2018 Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Sept. 25, 2018 Know the Lowest Price Act of 2018
Sept. 25, 2018 House Passes Bills to Lower Prescription Drug Costs, Improve Pandemic Preparedness
Sept. 25, 2018 Burgess Praises House Passage of Bills to Boost Preparedness and Support Critical Health Priorities
Sept. 20, 2018 Walden and Burgess on $1 Billion in Grants to Combat the Opioid Crisis
Sept. 20, 2018 Support for the Dr. Benjy Frances Brooks Children's Hospital GME Support Reauthorization Act of 2018
Sept. 18, 2018 Burgess Praises CHGME Law Named for Dr. Benjy Frances Brooks
Sept. 18, 2018 Burgess Praises CHGME Law Named for Dr. Benjy Frances Brooks
Sept. 18, 2018 Walden & Burgess on President Trump Signing Bipartisan Children's Hospital Graduate Medical Education Bill into Law
Sept. 17, 2018 Walden and Burgess on Senate Passage of Opioid Package
Sept. 7, 2018 #SubHealth Advances Bipartisan Bills to Improve Health Care
Sept. 5, 2018 Hearing of the House Energy and Commerce Committee - Chairman Michael Burgess, MD - Energy and Commerce Committee Subcommittee on Health "Opportunities to Improve Health Care"
Sept. 5, 2018 Walden and Burgess on Release of SAMHSA Grants to Help Combat the Opioid Crisis
Sept. 5, 2018 Walden and Burgess on Senate Passage of Bipartisan Bill Reauthorizing the Children's Hospital Graduate Medical Education Program
Aug. 30, 2018 Burgess Travels to Central America, Seeks Solutions to Secure Borders and Prevent Dangerous Crossings
Aug. 30, 2018 Letter to Pharmacy Benefit Mangers of CVS, EnvisionRXOptions, Express Scripts Holding Company, Humana Inc., Prime Therapeutics, Procare Pharmacy Benefit Manager, Inc., and UnitedHealth Group - Regarding their Role in the Drug Supply Chain
Aug. 30, 2018 Letter to Francis Crosson, MD, Chairman of the Medicare Payment Advisory Commission - Examine Cost Drivers of Health Care
Aug. 25, 2018 Burgess Statement on Senator John McCain
Aug. 16, 2018 Walden & Burgess Comment on FDA Approval of Generic EpiPen
Aug. 1, 2018 Walden and Burgess on Senate Passage of Bipartisan Bill Reauthorizing Animal Drug & Animal Generic Drug User Fee Programs
Aug. 1, 2018 Letter to Nine Contract Pharmacies that Participate in the 340B Drug Pricing Program - Letters Follow Report from Nonpartisan Watchdog & #SubHealth Hearing
Aug. 1, 2018 Walden and Burgess on Administration's Final Rule to Expand Short-Term Insurance Plans
July 31, 2018 Burgess Statement on Bill Becoming Law That Extends Deadline for States to Comply with Cures Act's EVV Provision
July 27, 2018 Letter to the Hon. Joseph Simons, Chairman of the Federal Trade Commission - E&C Leaders Request FTC Review PBM Mergers
July 26, 2018 Border Security
July 26, 2018 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Burgess, Hearing on MACRA and MIPS: An Update on the Merit-Based Incentive Payment System
July 25, 2018 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Burgess, Hearing on 21 st Century Cures: Updates from FDA and NIH
July 25, 2018 House Passes Bill Providing Lower Costs for Consumers Seeking Relief from Rising Premiums
July 23, 2018 Burgess Statement on Bills to Boost Health Care Workforce
July 23, 2018 Title VIII Nursing Workforce Reauthorization Act of 2018
July 23, 2018 Bill to Reauthorize the Children's Hospital Graduate Medical Education (CHGME) Program Passes House
July 23, 2018 Dr. Benjy Frances Brooks Children's Hospital Gme Support Reauthorization Act of 2018
July 23, 2018 Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness Act of 2018
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Thank You!

You are about to be redirected to a secure checkout page.

Please note:

The total order amount will read $0.01. This is a card processor fee. Please know that a recurring donation of the amount and frequency that you selected will be processed and initiated tomorrow. You may see a one-time charge of $0.01 on your statement.

Continue to secure page »

Back to top